International Clinical Harmonisation Proper Systems In Place Essay

International Clinical Harmonisation PROPER SYSTEMS IN PLACE

The International Congress Harmonisation

WHO Principles of Good Clinical Practice

Clinical research is conducted to insure the safety and efficacy of health and medical products and practices (WHO 2002). In the past, randomized controlled trials gave most of the information about the safety and efficacy of these products and treatments. Randomized clinical trials were considered the foundation of evidence-based medicine but reliably only when conducted according to principles and standards. These principles and standards comprise good clinical research or GCP. The guidelines were created to help national regulatory authorities, sponsors, investigators and ethics committees to implement GCP for overall clinical research. These were based on the guidelines provided by major international organizations, such as the International Conference on Harmonization or ICH GCP, and used as reference (WHO).

GCP incorporates accepted and established ethical and scientific quality standards complied with for the design, conduct, recording and reporting of clinical research with the participation of human subjects (WHO 2002). This compliance is a public guarantee of the rights, safety, and well-being of the subjects, as required by the Declaration of Helsinki and other relevant and internationally recognized ethical guidelines. It insures the reliability of the data that evolve from the research. The process is complex and made more complex by the involvement of a diverse group o experts who all need to perform skillfully and efficiently. These players are all responsible for GCP. They include sponsors, investigators and site staff, contract research organizations, ethics committees, regulatory authorities and respondents to research (WHO).

The 14 guiding principles of GCP surround human subjects of research (WHO 2002). It should be scientifically sound and conducted according to basic ethical principles emanating from the Declaration of Helsinki. The three basic ethical principles permeating all other GCP principles are respect for persons,...

...

It should be justified and described clearly. Before it is started, foreseeable risks and discomfort and anticipated benefits should be identified. The anticipated benefits should outweigh the risks as they relate to the respondents' rights, safety and well-being. It should be approved by an independent ethics committee or institutional review board beforehand. It should comply with approved protocol. Participating respondents should first provide informed consent according to their respective cultures and requirements. It should proceed only if the benefit is favorable as compared with the risks. Qualified and duly licensed medical personnel are responsible for their care and medical decisions for them. The medical staff should possess the appropriate education, training and experience for the task. All information proceeding from the research should be recorded, managed and kept safely for accurate retrieval, reporting, interpretation and verification. The records of participants should be kept private and confidential. Products ensuing from the research should be handled according to Good Manufacturing Practice and approved protocol. And systems and procedures, which assure the quality of each aspect of the trial, should be implemented (WHO).
International Congress on Harmonization

This was launched in 1990 for the purpose of connecting drug regulatory authorities and the pharmaceutical industry of Europe, Japan and the United States (ICH 2011). Regulatory harmonization will directly benefit these sectors in protecting public health. Benefits include the prevention of the duplication of clinical trials involving human subjects; the reduction of animal testing; streamlining the process for new drug applications; and reducing time and resources needed for developing. These are the advantages of harmonizing trials worldwide. Harmonization is in turn achieved by observing ICH Tripartite guidelines. The guidelines were drawn from the scientific consensus of regulatory and industry experts who work together. Commitment of these regulators to implementing the final guidelines is paramount to the…

Sources Used in Documents:

BIBLIOGRAPHY


Cite this Document:

"International Clinical Harmonisation Proper Systems In Place" (2011, December 11) Retrieved April 19, 2024, from
https://www.paperdue.com/essay/international-clinical-harmonisation-proper-53312

"International Clinical Harmonisation Proper Systems In Place" 11 December 2011. Web.19 April. 2024. <
https://www.paperdue.com/essay/international-clinical-harmonisation-proper-53312>

"International Clinical Harmonisation Proper Systems In Place", 11 December 2011, Accessed.19 April. 2024,
https://www.paperdue.com/essay/international-clinical-harmonisation-proper-53312

Related Documents

Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this

Abuse and Pregnant Women
PAGES 40 WORDS 13948

Violence against pregnant women is a commonplace phenomenon and this research paper will explain the background of violence against pregnant women. Women undergo different forms of violence for instance, beating, threats, raping and unwilling prostitution. Some years back, it wasn't a big issue as approach towards women was a tad bit different back then. Men were treated as the dominant sex due to their physical strength. So is the case

ER Practices in Atlanta
PAGES 5 WORDS 28237

Economic Motivators for Employers on Employment Rates for People With Disabilities in Atlanta Qualitative Research Quantitative Research Definition of Disability Statistics for Individuals with Disabilities Effects Of ADA On Persons With Disabilities Economic Motivators for Employers Hiring People with Disabilities Factors Affecting Economic Motivators for Employers Lack of Information and Knowledge Regarding Economic Motivators Misconception about Individuals with Disabilities Inaccessible Hiring Strategies Conflicts with Existing Programs Lack of Appropriate Planning and Difficulties in implementations Economic Incentive Programs Unemployment Among People with Disabilities Summary Conclusion CHAPTER

Economic Motivators for Employers on Employment Rates for People With Disabilities in Atlanta Qualitative Research Quantitative Research Definition of Disability Statistics for Individuals with Disabilities Effects Of ADA On Persons With Disabilities Economic Motivators for Employers Hiring People with Disabilities Factors Affecting Economic Motivators for Employers Lack of Information and Knowledge Regarding Economic Motivators Misconception about Individuals with Disabilities Inaccessible Hiring Strategies Conflicts with Existing Programs Lack of Appropriate Planning and Difficulties in implementations Economic Incentive Programs Unemployment Among People with Disabilities Summary Conclusion CHAPTER